← All Companies

Fourier Intelligence

GR-1 / GR-2
2024 Market Share
6.2%
Founded 2015·Shanghai, China·Rehabilitation-to-humanoid, modular actuators, medical regulatory pathway
Units Produced 2024
~250
Units Target 2026
3,000
Total Funding
$200M+

Approach

Proven actuator technology from medical devices. FSA (Fourier Smart Actuator) series. FDA pathway for healthcare applications.

Technical Specifications

Height
165 cm
Weight
55 kg
DOF
40 (GR-2)
Payload
50 kg (HIGHEST)
Runtime
5 hrs
Speed
1.4 m/s (5.0 km/h)
Price
Not disclosed

Strengths

  • +Proven FSA actuator tech from rehabilitation robotics
  • +50 kg payload — HIGHEST in industry
  • +FDA medical device pathway gives unique regulatory edge
  • +Modular joint design enables customer-specific configurations
  • +Strong Asian healthcare market presence

Vulnerabilities

  • −Medical regulatory pathway is slow and expensive (2-5 years)
  • −Consumer/industrial market entry is recent
  • −Chinese geopolitical exposure

Component Story

FSA (Fourier Smart Actuator) proprietary design originally developed for rehab exoskeletons. Modular architecture allows mixing and matching joints for different applications. NOTE: Speed often cited as 5.0 m/s in marketing — this is almost certainly a unit error (5 m/s = 18 km/h = faster than human sprint). Correct figure is 5.0 km/h (1.4 m/s).

Actuators
FSA in-house proprietary
Compute
Embedded AI (unspecified)
Battery
Chinese Li-ion
Sensors
Multi-sensor fusion

Funding History

YearRoundAmountLead Investors
2025Series E (January 2025)¥800M ($109M)Guoxin Investment, Pudong VC

Key Partners

China Mobile subsidiaries
Current Status
GR-2 shipping, medical pilots running
Source: Ch.7 Competitive Landscape v2